The agreement offers Amerinet members and partners access to MedGraphic’s systems that diagnose and monitor therapy in a wide spectrum of heart and lung disorders, such as congestive heart failure, asthma and other forms of chronic obstructive pulmonary disease (COPD).

With MedGraphic’s full clinical product line, Amerinet customers will be able to offer simple spirometry or breath measurement in clinics and physician offices; complete pulmonary function testing in hospital laboratories; assess cardiopulmonary exercise in rehabilitation and sports medicine centers; and provide nutritional evaluations in critical care units.

MedGraphic’s technologies provide clinical professionals with essential information to noninvasively assess and successfully manage their patients’ care. These cardiorespiratory diagnostic products are used in leading medical centers throughout the US and in more than 75 countries around the world.

Rodney Young, president and chief executive officer of Angeion, said: “We are pleased that Amerinet, one of the nation’s largest group purchasing organizations, recognizes the diagnostic value that our MedGraphic’s systems can provide to the patients and physicians in their network. We share Amerinet’s goal of providing high quality care and reducing costs across the entire continuum of health.”